115
Views
0
CrossRef citations to date
0
Altmetric
Research Articles

Reactivity of N-(4-Nitrophenyl)propionohydrazonoyl Bromide. Synthesis and Antimicrobial Study of Thiadiazoles and 4,6-Dithia-1,2,9-triazaspiro-[4.4]-non-2-en-8-ones

ORCID Icon, , , ORCID Icon & ORCID Icon
Pages 572-585 | Received 10 Sep 2021, Accepted 02 Dec 2021, Published online: 22 Dec 2021

References

  • L. M. Rangwala, and G. T. Liu, “Pediatric Idiopathic Intracranial Hypertension,” Survey of Ophthalmology 52, no. 6 (2007): 597–617.
  • M. B. Russell, and A. Ducros, “Sporadic and Familial Hemiplegic Migraine: pathophysiological Mechanisms, Clinical Characteristics, Diagnosis, and Management,” The Lancet. Neurology 10, no. 5 (2011): 457–70.
  • P. Sah, P. Bidawat, M. Seth, and C. P. Gharu, “Synthesis of Formazans from Mannich Base of 5-(4-Chlorophenyl Amino)-2-Mercapto-1,3,4-Thiadiazole as Antimicrobial Agents,” Arabian Journal of Chemistry. 7, no. 2 (2014): 181–7.
  • A. Foroumadi, Z. Kiani, and F. Soltani, “Antituberculosis Agents VIII: Synthesis and in Vitro Antimycobacterial Activity of Alkyl α-[5-(5-Nitro-2-Thienyl)-1,3,4-Thiadiazole-2-yl-Thio]-Acetates,” Il Farmaco 58, no. 11 (2003): 1073–6.
  • D. Sunil, A. M. Isloor, P. Shetty, K. Satyamoorthy, and A. S. B. Prasad, “6-[3-(4-Fluorophenyl)-1H-Pyrazol-4-yl]-3-[(2-Naphthyloxy)Methyl][1,2,4]Triazolo[3,4-b][1,3,4]Thia-Diazole as a Potent Antioxidant and an Anticancer Agent Induces Growth Inhibition Followed by Apoptosis in HepG2 Cells,” Arabian Journal of Chemistry. 3, no. 4 (2010): 211–17.
  • E. Palaska, G. Sahin, P. Kelicen, N. T. Durlu, and G. Altinok, “Synthesis and anti-Inflammatory Activity of 1-Acylthiosemicarbazides, 1,3,4-Oxadiazoles, 1,3,4-Thiadiazoles and 1,2,4-Triazole-3-Thiones,” Farmaco (Societa Chimica Italiana: 1989) 57, no. 2 (2002): 101–7.
  • V. Jatav, P. Mishra, S. Kashaw, and J. P. Stables, “CNS Depressant and Anticonvulsant Activities of Some Novel 3-[5-Substituted 1,3,4-Thiadiazole-2-yl]-2-Styryl Quinazoline-4(3H)-Ones,” European Journal of Medicinal Chemistry. 43, no. 9 (2008): 1945–54.
  • Wojciech Rzeski, Joanna Matysiak, and Martyna Kandefer-Szerszeń, “Anticancer, Neuroprotective Activities and Computational Studies of 2-Amino-1,3,4-Thiadiazole Based Compound,” Bioorganic & Medicinal Chemistry 15, no. 9 (2007): 3201–7.
  • I. P. Kaur, R. Smitha, D. Aggarwal, and M. Kapil, “Acetazolamide: future Perspective in Topical Glaucoma Therapeutics,” International Journal of Pharmaceutics 248, no. 1-2 (2002): 1–14.
  • A. M. Luks, S. E. McIntosh, C. K. Grissom, P. S. Auerbach, G. W. Rodway, R. B. Schoene, K. Zafren, and P. H. Hackett, “Wilderness Medical Society Consensus Guidelines for the Prevention and Treatment of Acute Altitude Illness,” Wilderness & Environmental Medicine 21, no. 2 (2010): 146–55.
  • P. Wolf, “Acute Drug Administration in Epilepsy: A Review,” CNS Neuroscience & Therapeutics 17no. 5 (2011): 442–8.
  • H. G. Tiselius, “New Horizons in the Management of Patients with Cystinuria,” Current Opinion in Urology 20, no. 2 (2010): 169–73.
  • U. Schara, and H. Lochmuller, “Therapeutic Strategies in Congenital Myasthenic Syndromes,” Neurotherapeutics : The Journal of the American Society for Experimental NeuroTherapeutics 5, no. 4 (2008): 542–7.
  • H. M. Kuo, S. Y. Li, H. S. Sheu, and C. K. Lai, “Symmetrical Mesogenic 2,5-Bis(6-Naphthalen-2-yl)-1,3,4-Thiadiazoles,” Tetrahedron 68, no. 36 (2012): 7331–7.
  • V. Polshettiwar, and R. S. Varma, “Greener and Rapid Access to Bio-Active Heterocycles: one-Pot Solvent-Free Synthesis of 1,3,4-Oxadiazoles and 1,3,4-Thiadiazoles,” Tetrahedron Letters. 49, no. 5 (2008): 879–83.
  • J. Mirzaei, M. Amini, H. Pirelahi, and A. Shafiee, “Convenient Syntheses of 5‐[(2‐Methyl‐5‐Nitro‐1H‐Imidazol‐1‐yl) Methyl]‐1, 3, 4‐Oxadiazole‐2 (3H) Thione and N‐Substituted 2‐Amino‐5‐[(2‐Methyl‐5‐Nitro‐1H‐Imidazol‐1‐yl) Methyl]‐1, 3, 4‐Thiadiazoles,” Journal of Heterocyclic Chemistry 45, no. 3 (2008): 921–5.
  • Y. Zuo, S. G. Yang, L. L. Jiang, G. F. Hao, Z. F. Wang, Q. Y. Wu, Z. Xi, and G. F. Yang, “Quantitative Structure-Activity Relationships of 1,3,4-Thiadiazol-2(3H)-Ones and 1,3,4-Oxadiazol-2(3H)-Ones as Human Protoporphyrinogen Oxidase Inhibitors,” Bioorganic & Medicinal Chemistry 20, no. 1 (2012): 296–304.
  • C. T. Liao, Y. J. Wang, C. S. Huang, H. S. Sheu, G. H. Lee, and C. K. Lai, “New Metallomesogens Derived from Unsymmetric 1,3,4-Thiodiazoles: synthesis, Single Crystal Structure, Mesomorphism, and Optical Properties,” Tetrahedron 63, no. 50 (2007): 12437–45.
  • V. Padmavathi, S. N. Reddy, G. D. Reddy, and A. Padmaja, “Synthesis and Bioassay of Aminosulfonyl-1,3,4-Oxadiazoles and Their Interconversion to 1,3,4-Thiadiazoles,” European Journal of Medicinal Chemistry 45, no. 9 (2010): 4246–51.
  • V. Padmavathi, G. S. Reddy, A. V. N. Mohan, and K. Mahesh, “Synthesis of Symmetrical and Unsymmetrical 1,3,4-Oxadiazoles and Their Interconversion to 1,3,4-Thiadiazoles and 1,2,4-Triazoles,” Arkivoc 2008, no. 17 (2009): 48–60.
  • G. Tu, S. Li, H. Huang, G. Li, F. Xiong, X. Mai, H. Zhu, B. Kuang, and W. F. Xu, “Novel Aminopeptidase N Inhibitors Derived from 1,3,4-Thiadiazole Scaffold,” Bioorganic & Medicinal Chemistry 16, no. 14 (2008): 6663–8.
  • S. G. Alegaon, K. R. Alagawadi, P. V. Sonkusare, S. M. Chaudhary, D. H. Dadwe, and A. S. Shah, “Novel Imidazo[2,1-b][1,3,4]Thiadiazole Carrying Rhodanine-3-Acetic Acid as Potential Antitubercular Agents,” Bioorganic & Medicinal Chemistry Letters 22, no. 5 (2012): 1917–21.
  • V. Jatav, S. Kashaw, and P. Mishra, “Synthesis, Antibacterial and Antifungal Activity of Some Novel 3-[5-(4-Substituted Phenyl) 1,3,4-Thiadiazole-2-yl]-2-Styryl Quinazoline-4(3H)-Ones,” Medicinal Chemistry Research 17, no. 2–7 (2008): 169–81.
  • H. Takechi, Y. Oda, N. Nishizono, K. Oda, and M. Machida, “Screening Search for Organic Fluorophores: syntheses and Fluorescence Properties of 3-Azolyl-7-Diethylaminocoumarin Derivatives,” Chemical & Pharmaceutical Bulletin 48, no. 11 (2000): 1702–10.
  • A. R. Sayed, “Synthesis of Novel Thiadiazoles and Bis-Thiadiazoles from Carbonothioic Dihydrazide,” Tetrahedron Letters. 51, no. 34 (2010): 4490–3.
  • M. X. Wei, L. Feng, X. Q. Li, X. Z. Zhou, and Z. H. Shao, “Synthesis of New Chiral 2,5-Disubstituted 1,3,4-Thiadiazoles Possessing Gamma-Butenolide Moiety and Preliminary Evaluation of in Vitro Anticancer Activity,” European Journal of Medicinal Chemistry 44, no. 8 (2009): 3340–4.
  • J. Garfunkle, C. Ezzili, T. J. Rayl, D. G. Hochstatter, I. Hwang, and D. L. Boger, “Optimization of the Central Heterocycle of Alpha-Ketoheterocycle Inhibitors of Fatty Acid Amide Hydrolase,” Journal of Medicinal Chemistry 51, no. 15 (2008): 4392–403.
  • A. A. Hassan, A. F. E. Mourad, K. M. El-Shaieb, A. H. Abou-Zied, and D. Dopp, “Thermolysis of Symmetrical Dithiobiurea and Thioureidoethylthiourea Derivatives,” Heteroatom Chemistry 14, no. 6 (2003): 535–41.
  • A. A. Hassan, A. F. E. Mourad, K. M. El-Shaieb, and A. H. Abou-Zied, “Synthesis of 1,3,4-Thiadiazole, 1,3,4-Thiadiazine, 1,3,6-Thiadiazepane and Quinoxaline Derivatives from Symmetrical Dithiobiureas and Thioureidoethylthiourea Derivatives,” Molecules (Basel, Switzerland) 10, no. 7 (2005): 822–32.
  • A. Sami Shawali, and A. Osman Abdelhamid, “New Routes to Aroylthiadiazolines and Arylazothiazoles from Phenylglyoxalyl Bromide Arylhydrazones and Phenacyl Thiocyanate,” Journal of Heterocyclic Chemistry 13, no. 1 (1976): 45–9..
  • S. Ahmad, A. S. Shawali, and H. M. Hassaneen, “Chemistry of Aliphatic Hydrazonyl Bromides. I. Reactions of N-(4-Nitrophenyl) Aceto-Hydrazonyl Bromide with Nucleophiles and 1,3-Dipolarophiles,” Indian Journal of Chemistry 14, (1976): 425.
  • H. M. Hassaneen, and H. A. H. Mousa, “C-(2-Thinyl)-N-Arylformohydrazidoyl Chlorides in the Synthesis of Selenadiazolines and Thiadiazolines,” Sulfur Letters 7, (1988): 93.
  • H. M. Hassaneen, A. S. Shawali, and T. A. Abdallah. “One-Step Synthesis of 2,3-Dihydrothiadiazole Derivatives from Hydrazonoyl Halides,” Sulfur Letters 15, (1992): 103.
  • D. Pocar, L. M. Rossi, and R. Stradi, “Preparation of 1-Aryl-4,5- and 5,5-Diamino-4,5-Dihydropyrazoles and 4- and 5-Amino-1-Arylpyrazoles,” Synthesis 1976, no. 10 (1976): 684–5..
  • P. Wolkoff, S. T. Nemeth, and M. S. Gibson, “Reaction of Hydrazonyl Halides with Derivatives of Thiourea and Thiosemicarbazide; a New Source of C-Amino-and C-Hydrazino-1,2,4-Triazoles,” Canadian Journal of Chemistry 53, no. 21 (1975): 3211–15..
  • S. M. Gomha, M. M. Edrees, Z. A. Muhammad, and A. A. El-Reedy, “5-(Thiophen-2-Yl)-1,3,4-Thiadiazole Derivatives: Synthesis, Molecular Docking and in Vitro Cytotoxicity Evaluation as Potential Anticancer Agents,” Drug Design, Development and Therapy 12 (2018) : 1511–23.
  • F. M. Saleh, A. O. Abdelhamid, and H. M. Hassaneen, “Synthesis and Antimicrobial Activity of New Thiazole and Thiadiazole Derivatives via Ethyl Pyruvate,” Journal of Sulfur Chemistry 41, no. 2 (2020): 130–45..
  • N. F. Eweiss, and A. Osman, “Synthesis of Heterocycles. Part II. New Routes to Acetylthiadiazolines and Alkylazothiazoles,” Journal of Heterocyclic Chemistry 17, no. 8 (1980): 1713–7..
  • A. M. Farag, H. M. Hassaneen, I. M. Abbas, A. S. Shawali, and M. S. Algharib, “Synthesis and Reactions of Some 2-Thienyl- and 2-Thenoyl-Derivatives of Thiazole and Thiadiazoline and Their Selenium Analogs,” Phosphorous and Sulfur and the Related Elements 40, no. 3–4 (1988): 243–9..
  • Hassaneen, H. M. Elwan, N. M. Abdelhadi, H. A, and A. T. A. “Reactions of Hydrazonoyl Halides with 3-Thioxo-1,2,4-Triazin-5-Ones. Synthesis of 1,2,4-Triazolo[4,3-b][1,2,4]-Triazin-5-One,” Sulfur Letters 18, (1995): 121.
  • N. M. Elwan, H. M. Hassaneen, and H. M. Hassaneen, “Synthesis and Reactions of Indane‐1, 3‐Dione‐2‐Thiocarboxanilides with Hydrazonoyl Halides and Active Chloromethylene Compounds,” Heteroatom Chemistry 13, no. 7 (2002): 585–91..
  • S. Görges, H. Kristen, K. Peseke, and I. Farkas, “Synthesen Von C‐Nucleosiden Und C‐Nucleosidanaloga. I. Darstellung Von 1‐(D‐Galacto‐2,3,4,5,6‐Pentakisacetoxyhexan-Oyl)‐3‐Alkyl‐Oder Arylamino‐6, 6‐Dimethyl‐4,5,6,7‐Tetrahydro‐Benzo[c]Thiophen‐4‐Onen,” Journal Für Praktische Chemie 325, no. 1 (1983): 143–7..
  • A. A. Fadda, E. Abdel-Latif, and R. E. el-Mekawy, “Synthesis and Molluscicidal Activity of Some New Thiophene, Thiadiazole and Pyrazole Derivatives,” European Journal of Medicinal Chemistry 44, no. 3 (2009): 1250–6.
  • H. M. Hassaneen, H. M. Hassaneen, and Y. S. Mohammed, “Reactivity of 1-Methylisoquinoline Synthesis of Pyrazolyl Triazoloisoquinoline and Thia-Diazolyl Isoquinoline Derivatives,” Natural Science 03, no. 08 (2011): 651–60.
  • H. M. Hassaneen, H. M. Hassaneen, and Z. A. Gomaa, “Reactivity of 3-Cyanoacetylindole Derivatives: Synthesisof 3-Hydrazonopyrazolyl and 3-Thiadiazolyl Indole Derivatives,” International Journal of Organic Chemistry 01, no. 03 (2011): 97–104.
  • L. F. Audrieth, E. S. Scott, and P. S. Kippur, “Hydrazine Derivatives of the Carbonic and Thiocarbonic Acids. I. The Preparation and Properties of Thiocarbohydrazide,” The Journal of Organic Chemistry 19, no. 5 (1954): 733–41.
  • D. L. Klayman, J. F. Bartosevich, T. S. Griffin, C. J. Mason, and J. P. Scovill, “2-Acetylpyridine Thiosemicarbazones. 1. A New Class of Potential Antimalarial Agents,” Journal of Medicinal Chemistry 22, no. 7 (1979): 855–62.
  • H. F. Zohdi, H. A. Emam, and A. O. Abdelhamid, “Reactions with Hydrazonoyl Halides XIV [1]. a Convenient Synthesis of 2,3-Dihydro-1,3,4-Thiadiazole Derivatives,” Phosphorus. Sulfur, Silicon and the Related Elements 129, no. 1 (1997): 147–54.
  • H. A. Emam, H. F. Zohdi, and A. O. Abdelhamid, “Reactions with Hydrazonoyl Halides. Part 15.1 a Synthetic Approach to 2,3-Dihydrothiadiazoles,” Journal of Chemical Research 1, no. 1 (1998): 12–13.
  • H. F. Zohdi, N. M. Rateb, M. M. Sallam, and A. O. Abdelhamid, “Reactions with Hydrazonoyl Halides. Part 20. 1 Synthesis of New Unsymmetrical Azines, Dihydro-1,3,4-Thiadiazoles and 5-Arylazothiazoles,” Journal of Chemical Research 12, no. 12 (1998): 742–3.
  • M. I. Ionescu, and O. Oniga, “Molecular Docking Evaluation of (E)-5-Arylidene-2-Thioxothiazolidin-4-One Derivativesas Selective Bacterial Adenylate Kinase Inhibitors,” Molecules 23, no. 5 (2018): 1076.
  • A. S. Shawali, “Chemoselectivity in 1,3-Dipolar Cycloaddition Reactions of Nitrilimines with Multifunctionalized Dipolarophiles,” Current Organic Chemistry 18, (2014): 598.
  • H. M. Hassaneen, H. A. Daboun, H. A. Abd El-Hadi, and N. A. Abd El-Reheim, “Site Selectivity and Regiochemistry of Nitrilimines. Cycloadditions to 1, 3-Diphenyl-2-Thiono-4-Imidazolidinone and Its 5-Phenylmethylene Derivatives,” Phosphorus, Sulfur, Silicon and the Related Elements 107, no. 1–4 (1995): 269–73.
  • Z. Z. Geng, J.-J. Zhang, J. Lin, M. Y. Huang, L.-K. An, H.-B. Zhang, P.-H. Sun, W.-C. Ye, and W. M. Chen, “Novel Cajaninstilbene Acid Derivatives as Antibacterial Agents,” European Journal of Medicinal Chemistry 100 (2015): 235–45.
  • X. Lei, J. Li, B. Liu, N. Zhang, and H. Liu, “Separation and Identification of Four New Compounds with Antibacterial Activity from Portulaca oleracea L,” Molecules (Basel, Switzerland) 20, no. 9 (2015): 16375–87.
  • A. K. Jordão, J. Novais, B. Leal, A. C. Escobar, H. M. dos Santos Júnior, H. C. Castro, and V. F. Ferreira, “Synthesis Using Microwave Irradiation and Antibacterial Evaluation of New N, O-Acetals and N, S-Acetals Derived from 2-Amino-1, 4-Naphthoquinones,” European Journal of Medicinal Chemistry 63, (2013): 196–201.
  • A. W. Bauer, W. M. Kirby, J. C. Sherris, and M. Turck, “Antibiotic Susceptibility Testing by a Standardized Single Disk Method,” American Journal of Clinical Pathology 45, no. 4 (1966): 493–6.
  • M. A. Pfaller, L. Burmeister, M. S. Bartlett, and M. G. Rinaldi, “Multicenter Evaluation of Four Methods of Yeast Inoculum Preparation,” Journal of Clinical Microbiology 26, no. 8 (1988): 1437–41.
  • J. H. Rex, E. M. Johnson, M. A. Ghannoum, C. C. Knapp, B. D. Alexander, M. R. Motyl, D. Andes, L. Ostrosky-Zeichner, S. D. Brown, and M. A. Pfaller. Method for Antifungal Disk Diffusion Susceptibility Testing of Yeasts: Approved Guideline M44-A ( 2009), 24.
  • N. Suresh, H. N. Nagesh, J. Renuka, V. Rajput, R. Sharma, I. A. Khan, and C. S. K. V. Gowri, “Synthesis and Evaluation of 1-Cyclopropyl-6-Fluoro-1,4-Dihydro-4-Oxo-7-(4-(2-(4-Substitutedpiperazin-1-Yl)Acetyl)Piperazin-1-Yl)Quinoline-3-Carboxylic Acid Derivatives as anti-Tubercular and Antibacterial Agents,” European Journal of Medicinal Chemistry 71, (2014): 324–32.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.